Morgan Stanley analyst Annelies Vermeulen upgraded Rentokil Initial (RTO) to Overweight from Equal Weight with a price target of 520 GBp, up from 450 GBp. The firm adjusted rating in the European business services group as part of its 2026 outlook. The analyst is cautious on the staffers and chemical distribution. Morgan Stanley’s preferred stocks for 2026 are Experian, Diploma, Rentokil, Verisure, Bureau Veritas and ISS.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RTO:
- Rentokil Initial: Attractive Entry Point and Margin Upside Underpin Upgrade to Buy
- Rentokil Initial upgraded to Buy from Neutral at BofA
- Swedbank Robur Fonder AB Adjusts Stake in Rentokil Initial
- Rentokil Initial Announces Change in Major Shareholder Holdings
- Rentokil Initial Announces Change in Major Holdings